As of 4:00pm ET
| +0.20 / +1.93%|
The 6 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 15.50, with a high estimate of 31.50 and a low estimate of 11.00. The median estimate represents a +46.92% increase from the last price of 10.55.
The current consensus among 6 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.